Hye Jeong Oh

566 total citations
14 papers, 381 citations indexed

About

Hye Jeong Oh is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Hye Jeong Oh has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Hye Jeong Oh's work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (3 papers) and Phagocytosis and Immune Regulation (3 papers). Hye Jeong Oh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (3 papers) and Phagocytosis and Immune Regulation (3 papers). Hye Jeong Oh collaborates with scholars based in South Korea, United States and China. Hye Jeong Oh's co-authors include In‐Hye Ham, Hoon Hur, Sang‐Uk Han, Rolf A. Brekken, Dakeun Lee, Hyejin Jin, Sang‐Yong Son, Cheong A Bae, Sang‐Min Jeon and Kyeong Sook Choi and has published in prestigious journals such as Gut, British Journal of Cancer and Life Sciences.

In The Last Decade

Hye Jeong Oh

12 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hye Jeong Oh South Korea 7 198 156 99 74 65 14 381
Natascha Cremers Germany 11 290 1.5× 239 1.5× 92 0.9× 137 1.9× 38 0.6× 12 516
Preston D. Moore United States 5 193 1.0× 121 0.8× 87 0.9× 67 0.9× 28 0.4× 9 381
Yongzhang Luo China 9 180 0.9× 221 1.4× 76 0.8× 69 0.9× 23 0.4× 12 381
Chee Man Cheong Australia 8 155 0.8× 259 1.7× 45 0.5× 98 1.3× 26 0.4× 10 434
Leili Saeednejad Zanjani Iran 13 201 1.0× 273 1.8× 74 0.7× 114 1.5× 22 0.3× 37 497
Kazuaki Fushimi Japan 15 135 0.7× 333 2.1× 52 0.5× 131 1.8× 28 0.4× 22 486
Arin Nam United States 11 150 0.8× 274 1.8× 72 0.7× 119 1.6× 44 0.7× 22 443
Hee-Jung Byun South Korea 8 128 0.6× 254 1.6× 102 1.0× 106 1.4× 177 2.7× 8 477
Zi-Hao Qi China 8 269 1.4× 217 1.4× 135 1.4× 168 2.3× 19 0.3× 9 523
Christine Rivat France 7 171 0.9× 284 1.8× 143 1.4× 71 1.0× 36 0.6× 7 503

Countries citing papers authored by Hye Jeong Oh

Since Specialization
Citations

This map shows the geographic impact of Hye Jeong Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye Jeong Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye Jeong Oh more than expected).

Fields of papers citing papers by Hye Jeong Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye Jeong Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye Jeong Oh. The network helps show where Hye Jeong Oh may publish in the future.

Co-authorship network of co-authors of Hye Jeong Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Hye Jeong Oh. A scholar is included among the top collaborators of Hye Jeong Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye Jeong Oh. Hye Jeong Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kim, Tae Hoon, Hye Jeong Oh, In‐Hye Ham, et al.. (2025). Cancer-associated fibroblast-derived GAS6 increases resistance to chemotherapy through AXL/STAT3/ABCG1 in gastric cancer. British Journal of Cancer. 134(1). 72–84.
2.
3.
Ham, In‐Hye, Hye Jeong Oh, Jung Hwan Yoon, et al.. (2024). Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin β1. Journal of Translational Medicine. 22(1). 154–154. 6 indexed citations
4.
Kim, Tae Hoon, Hye Jeong Oh, In‐Hye Ham, et al.. (2023). Targeting GAS6/AXL signaling improves the response to immunotherapy by restoring the anti-immunogenic tumor microenvironment in gastric cancer. Life Sciences. 335. 122230–122230. 3 indexed citations
5.
Choi, Jun Yong, Hye Jeong Oh, In‐Hye Ham, et al.. (2022). Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer. Cancer Research and Treatment. 55(1). 167–178. 5 indexed citations
6.
Oh, Hye Jeong, et al.. (2021). Sporadic amyotrophic lateral sclerosis with seropositive neuromyelitis optica spectrum disorder. Medicine. 100(16). e25580–e25580. 2 indexed citations
7.
Bae, Cheong A, In‐Hye Ham, Hye Jeong Oh, et al.. (2020). Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma. Gastric Cancer. 23(5). 824–836. 36 indexed citations
8.
Ham, In‐Hye, Hye Jeong Oh, Hyejin Jin, et al.. (2019). Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Molecular Cancer. 18(1). 68–68. 193 indexed citations
9.
Kim, Yuntae, et al.. (2019). Subacute combined degeneration associated with vitamin E deficiency due to small bowel obstruction. Medicine. 98(36). e17052–e17052. 3 indexed citations
10.
Oh, Hye Jeong, et al.. (2019). Scaffold-Assisted Ectopic Transplantation of Internal Organs and Patient-Derived Tumors. ACS Biomaterials Science & Engineering. 5(12). 6667–6678. 7 indexed citations
11.
Oh, Hye Jeong, Ho Geol Woo, Jin Myoung Seok, & Kwang Ik Yang. (2019). Central Sleep Apnea without Cheyne-Stokes Breathing Following an Acute Cerebral Infarction. 16(1). 53–55.
12.
Jin, Hyejin, In‐Hye Ham, Hye Jeong Oh, et al.. (2018). Inhibition of Discoidin Domain Receptor 1 Prevents Stroma-Induced Peritoneal Metastasis in Gastric Carcinoma. Molecular Cancer Research. 16(10). 1590–1600. 40 indexed citations
13.
Hur, Hoon, In‐Hye Ham, Dakeun Lee, et al.. (2017). Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma. BMC Cancer. 17(1). 87–87. 51 indexed citations
14.
Park, Young Hoon, et al.. (2010). Rose (Rosa hybrida L.) EST-derived microsatellite markers and their transferability to strawberry (Fragaria spp.). Scientia Horticulturae. 125(4). 733–739. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natascha Cremers Breakdown of academic impact, for papers by Preston D. Moore Breakdown of academic impact, for papers by Yongzhang Luo Breakdown of academic impact, for papers by Chee Man Cheong Breakdown of academic impact, for papers by Leili Saeednejad Zanjani Breakdown of academic impact, for papers by Kazuaki Fushimi Breakdown of academic impact, for papers by Arin Nam Breakdown of academic impact, for papers by Hee-Jung Byun Breakdown of academic impact, for papers by Zi-Hao Qi Breakdown of academic impact, for papers by Christine Rivat
Rankless by CCL
2026